72,234 articles
INCAsE trial
INCAsE (NCT04204109) was a terminated cluster randomized trial at Rigshospitalet comparing interprofessional versus monoprofessional case-based learning on gastrointestinal toxicities in childhood cancer, enrolling 49 staff; distinct from the VA COPD InCasE trial.
INCENP
INCENP (inner centromere protein) is a 918-amino-acid human scaffold protein of the chromosomal passenger complex, binding Aurora B via its IN-box and survivin-borealin via its N-terminus to regulate chromosome segregation and cytokinesis.
Incentive spirometry
Incentive spirometry is a breathing therapy in which patients take slow, sustained maximal breaths through a handheld feedback device to expand the lungs and prevent atelectasis, chiefly after surgery.
Incidence (epidemiology)
Incidence in epidemiology is the frequency of new cases of disease in a population over a specified period, measured as incidence proportion (risk) or incidence rate (per person-time), distinct from prevalence, which counts all existing cases.
Incision and drainage
Incision and drainage (I&D) is a surgical procedure that cuts into an abscess to evacuate pus, achieving source control; more than 1.4 million are performed yearly in the United States.
Incisional biopsy
Incisional biopsy, contrasted with excisional biopsy, is a surgical diagnostic procedure removing only part of a lesion, used when malignancy needs tissue diagnosis before definitive surgery.
Incisional hernia repair
Incisional hernia repair is surgery to close and reinforce a hernia that developed at a previous abdominal incision site, using sutures, mesh, or both, with mesh repair preferred for larger defects.
Incisional negative pressure wound therapy
Incisional negative pressure wound therapy (ciNPWT, also called closed-incision negative pressure therapy) applies sealed suction dressings over fresh surgical incisions for several days, reducing surgical site infection and dehiscence in high-risk patients.
Incisor
Incisor: front tooth for cutting or gnawing in both jaws; humans have eight (central and lateral per quadrant). Covers anatomy, mamelons, shoveling, trauma management, and rodent ever-growing incisors.
Inclacumab
Inclacumab (RO4905417, RG1512, HuMab 002) is a fully human IgG4 anti-P-selectin monoclonal antibody blocking P-selectin-PSGL-1 binding, developed for sickle cell disease; its Phase 3 THRIVE-131 trial missed its VOC-reduction endpoint in 2025.
INCLINE-AMI trial
INCLINE-AMI (NCT07290699), a phase 4 randomized trial by the Second Affiliated Hospital of Nanchang University, tests recaticimab 450 mg every 12 weeks started within 24 hours of emergency PCI for acute myocardial infarction in 2,442 patients, versus standard statin therapy, over 6 months of treatment and 12-month follow-up.
Inclisiran
Inclisiran (brand name Leqvio) is a small interfering RNA drug targeting PCSK9 that lowers LDL cholesterol, given by subcutaneous injection twice a year and used with statins in adults with high cholesterol.
Inclusion bodies
Inclusion bodies are circumscribed deposits of foreign or metabolically inactive material in the cytoplasm or nucleus, spanning glycogen and lipid stores, viral replication compartments such as Negri bodies, and amyloid-like bacterial protein aggregates.
Inclusion body myopathy
Inclusion body myopathy (hIBM, hereditary myopathy with rimmed vacuoles) is a GNE-mutation hereditary muscle disease, distinct from sporadic inclusion body myositis, the inflammatory quadriceps and finger flexor myopathy over age 50.
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia
IBMPFD, now called multisystem proteinopathy (MSP1 when caused by VCP), is a rare autosomal dominant adult-onset disorder combining inclusion body myopathy, early Paget disease of bone, and frontotemporal dementia, with ALS and parkinsonism also in the spectrum.
Inclusion body myositis
Inclusion body myositis (IBM), also called sporadic inclusion body myositis, is a progressive inflammatory muscle disease beginning after age 50, marked by asymmetric finger-flexor and quadriceps weakness, rimmed vacuoles on biopsy, anti-cN1A antibodies, and resistance to immunosuppression.
Inclusive fitness
Inclusive fitness, from W. D. Hamilton's 1963–1964 papers, measures reproductive success including relatedness-weighted effects on others; basis of kin selection and Hamilton's rule rB > C, contested on additivity grounds.
Incoherence
Incoherence (ICD-11 MB25.03) is a formal thought disorder symptom: speech so disorganized it is incomprehensible to others, seen in psychosis, mania, and delirium, historically termed Wortsalat.
Incomplete defaecation
Incomplete defaecation, or sensation of incomplete evacuation, is the persistent feeling stool remains after a bowel movement; a Rome IV constipation criterion linked to dyssynergic defecation and obstructed defaecation syndrome.
Incomplete uterovaginal prolapse
Incomplete uterovaginal prolapse (ICD-11 GC40.30, ICD-10 N81.2) is partial descent of the uterus and vagina into the vaginal canal without protrusion beyond the introitus, typically after childbirth, causing pelvic heaviness and urinary symptoms.
Incontinence Pads
Absorbent pads, also called incontinence pads or bladder control pads, are disposable or washable products containing urine or faecal leakage. Key facts: four main designs, superabsorbent polymer cores absorbing over 30 times their weight, gender-specific cost-effectiveness findings, FDA Class I regulation.
Incontinentia pigmenti
Incontinentia pigmenti (Bloch-Sulzberger syndrome), X-linked dominant IKBKG/NEMO disorder mainly of females, with four-stage Blaschko-line skin lesions, retinal vasculopathy, seizures, and CNS anomalies.
iNCOVACC (BBV154)
iNCOVACC (BBV154) is Bharat Biotech's chimpanzee adenovirus 36-vectored intranasal COVID-19 vaccine encoding prefusion-stabilized ancestral spike, approved in India in 2022 as a two-dose primary series and heterologous booster for adults 18+.
Increased appetite
Increased appetite (ICD-11 MG43.9; hyperphagia, polyphagia) is an intermittent or persistent excess desire to eat versus an individual's norm. Causes include hyperthyroidism, diabetes, hypoglycemia, anxiety, bulimia, and drugs such as corticosteroids.
Increased cerebrospinal fluid production
Increased cerebrospinal fluid production (ICD-11 8D64.00), overproduction of CSF by the choroid plexus, chiefly in choroid plexus papilloma, causing communicating hydrocephalus; documented outputs up to 5 L/day.
Increased energy
Increased energy (ICD-11 MB22.4) is a symptom of unusually high felt energy availability, seen in manic and hypomanic episodes and in thyrotoxicosis, and distinct from fatigue as a separate construct.
Increased goal-directed activity
Increased goal-directed activity (ICD-11 MB22.5) is a core mania symptom required with mood change in DSM-5 and ICD-11 criterion A; its addition cut STEP-BD mania/hypomania prevalence by 48% without changing 1-year outcomes.
Increased libido
Increased libido (ICD-11 MB22.6) is a symptom: sexual desire or activity above the patient's own baseline. Distinct from hypersexuality/CSBD; caused by dopaminergic drugs, mania, brain lesions, SSRIs.
Increased sociability
Increased sociability (社交性の亢進) is an ICD-11 symptom category, code MB23.C, in which normal social inhibitions are diminished, producing an increased impulse to talk to others and overfamiliarity.
Incretin
Incretins are gut hormones, principally GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), secreted by intestinal K-cells and L-cells after meals; they amplify glucose-stimulated insulin secretion, produce the incretin effect, and ground diabetes and obesity drugs.